Physician profile
Ryan Seutter
NPI 1285808311
$10,354.22
in general payments reported to CMS, 2019-2025
40 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,167 · 2020: $861 · 2021: $1,791 · 2022: $2,010 · 2023: $2,109 · 2024: $1,182 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,525.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,475.98 | 2021-2025 | Micra, Selectsecure, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $1,200.93 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Janssen Pharmaceuticals, INC | $805.74 | 2019-2023 | Xarelto |
| Medtronic Vascular, INC. | $674.00 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $600.82 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $454.39 | 2019-2025 | Lifevest |
| Philips North America LLC | $351.74 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck6) Holter, Extended Holter |
| Astrazeneca Pharmaceuticals Lp | $342.17 | 2019-2023 | Farxiga |
| Pfizer INC. | $260.93 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $241.74 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $193.46 | 2021-2022 | |
| Cardiva Medical, INC. | $186.21 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Cordis US Corp. | $163.17 | 2025 | Mynx Control Venous |
| Abbott Laboratories | $156.97 | 2021-2025 | Merlin@Home, Gallant, Xience Skypoint |
| Astellas Pharma US INC | $151.75 | 2019-2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $146.59 | 2024-2025 | |
| Amgen INC. | $123.93 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $102.03 | 2019-2023 | Eliquis |
| Sanofi-Aventis U.S. LLC | $94.71 | 2019-2022 | |
| Biosense Webster, INC. | $59.97 | 2023-2025 | Carto 3, Na |
| Daiichi Sankyo INC. | $50.30 | 2023 | Injectafer |
| Amarin Pharma, INC. | $49.52 | 2021 | |
| Vital Connect, INC | $48.37 | 2024-2025 | Vitalpatch Rtm |
| Ethicon US, LLC | $42.59 | 2025 | Vistaseal, Stratafix, Surgicel Nu-Knit |
| Terumo Medical Corporation | $40.86 | 2019-2021 | |
| Baxter Healthcare | $33.97 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Cardiovascular Systems INC. | $32.24 | 2019-2020 | |
| Atricure, INC. | $30.68 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Teleflex LLC | $30.35 | 2023 | Supercross |
| Davol INC. | $30.05 | 2023 | Arista Ah Flexitip |
| Cardinal Health 200 LLC | $22.70 | 2020 | |
| Portola Pharmaceuticals, LLC | $21.42 | 2019 | |
| Alnylam Pharmaceuticals INC. | $21.26 | 2023 | Onpattro |
| Esperion Therapeutics, INC. | $19.48 | 2020 | |
| Abiomed | $18.32 | 2019 | |
| Becton, Dickinson and Company | $18.20 | 2019 | |
| Elutia, INC. | $16.54 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.87 | 2020 | |
| W. L. Gore & Associates, INC. | $13.55 | 2022 | |
| Penumbra, INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Seutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.